By Jake Velie, CPT, Founder, Chairman & CEO, National Integrative Health

Employers are getting squeezed from every direction on healthcare costs. That part is not new. What is changing is how they are starting to respond.¹ ²

For years, many plan sponsors treated high-cost healthcare as something to review after the fact. They got the renewal. They looked at the trend. They asked a few questions. Then they assumed the vendor stack had it covered.

That approach is breaking down.

U.S. healthcare costs have reached $5.7 trillion, more than $15,000 per person per year. At the same time, nearly 60% of surveyed employers told Marsh they plan to make benefits changes next year to help control costs.¹ ² That is not a minor adjustment. It is a signal that employers know the old model is not holding.

The conversation is also becoming more explicit about fiduciary duty. Plan sponsors are being pushed to understand and implement CAA provisions, meet fiduciary responsibilities, and build stronger processes aligned with ERISA requirements.³ This is not just a cost conversation anymore. It is a governance conversation.

That matters because the real problem is not only price. It is fragmentation.

The PBM may manage one piece. The TPA may manage another. The broker may see the problem but not operate the fix. The employer is left trying to connect the dots after the spend is already on the books.

That is why more employers are looking for partners who do more than administer benefits. They are looking for people who can help them act like fiduciaries.

High-cost claims make that need impossible to ignore. One outside analysis put it plainly: 80% of healthcare costs are driven by 20% of claimants, and 50% of healthcare costs are driven by 5% of claimants.⁴ When that much risk is concentrated in that few cases, passive oversight is not a strategy.

Pharmacy pressure only adds to it. Specialty medications now comprise nearly 80% of all new drug launches, and nearly half of those launches carry price tags above $150,000.⁵ Employers do not need more summaries telling them costs are rising. They need someone who can challenge the pathway before a bad default becomes a paid claim.

That is the shift happening now. Employers are asking harder questions. Where is spend concentrating? Which claims are being actively challenged? What alternatives were reviewed? Who owns the decision? How do we prove the plan bought well, not just processed correctly?

Those are fiduciary questions. And once employers start asking them, they usually realize generic oversight is not enough.

This is why specialized partners are getting more attention. Not because employers want another logo in the stack. They do not. They want control. They want accountability. They want a party that can step into the space between administration and outcome and actually manage the problem.

That does not require self-promotion to explain. It is simply where the market is headed. When costs rise, risk concentrates, and compliance expectations get tighter, employers move toward expertise that is operational, clinical, financial, and accountable at the same time.

The era of passive health plan oversight is ending.

And for employers who are serious about cost, that is a good thing.

Footnotes

1. Moving to Value Alliance, “Enough with the Blank Checks,” Sep. 15, 2026. Summary states that U.S. healthcare costs have reached $5.7 trillion, more than $15,000 per person per year, and frames a 12 to 24 month roadmap from passive payer to active fiduciary. Link shared by user: https://www.movingtovalue.org/enough-with-the-blank-checks?utm_campaign=7ebc36f3-b142-46b4-acf7-6228b99dc19c&utm_source=so&utm_medium=mail&cid=322adc3d-c936-40c5-815b-713c3ca416dd

2. PLANSPONSOR NewsDash, “Employers Gear Up for Biggest Healthcare Cost Spike in 20 Years,” Sep. 8, 2026. Summary notes that nearly 60% of surveyed employers told Marsh they planned to make benefits changes next year to help control costs.

3. PLANSPONSOR, “Your Health Benefit Fiduciary Roadmap Starts Here!,” Mar. 25, 2026. Invitation copy states the series would help plan sponsors and advisers understand and implement CAA provisions, confidently meet fiduciary responsibilities, and build robust processes aligned with ERISA requirements.

4. AHealthcareZ, Eric Bricker, MD, “#1 Cause of High Healthcare Costs is…,” Oct. 28, 2025. Summary states that 80% of healthcare costs are driven by 20% of claimants and 50% of healthcare costs are driven by 5% of claimants.

5. RxBenefits Team, “Take Control of Specialty Drug Costs,” Aug. 24, 2026. Summary states that specialty medications comprise nearly 80% of all new drug launches and nearly half of them carry price tags exceeding $150,000.